While some parents can’t wait to vaccinate their young children against COVID-19, others remain hesitant. Your questions answered.
Author: Karen Weintraub, USA TODAY
CDC recommends COVID-19 vaccines for youngest Americans; shots will become available as soon as Tuesday
The actions clear the way for 10 million COVID-19 vaccine doses to begin delivery and distribution to young children as soon as Tuesday.
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland’s Novavax
A more traditional vaccine than some of the others, Novavax’s offering might encourage some COVID-19 vaccine holdouts to get the shot, experts said.
Diabetes drug helps patients lose never-before-seen amounts of weight, study shows
A study of the Type 2 diabetes drug tirzepatide found it resulted in dramatic weight loss, offering hope for those struggling with obesity.
As new diseases emerge and old ones surprise us, infectious disease doctors work overtime
Just in the last decade, scientists have been faced with identifying a handful of never-before-seen human diseases or unusual paths of known ones.
Monkeypox cases may be mistaken for a sexual transmitted disease, CDC warns
So far, 5 Americans are likely infected with monkeypox, the CDC said Monday. Health officials are trying to determine how the cases may be connected.
COVID antivirals can save lives, but access is still limited. Biden announces plan to change that.
Underused COVID-19 antivirals such as Paxlovid could save more lives. The Biden administration pledges to make them more available.
Why do my dogs smell like orange slices? The latest research on how COVID messes with smell
Most people hit early with coronavirus lost their smell. Now, not so much. Scientists are starting to figure out why and what that means.
Effective treatments for COVID are now available. Why are they not being used?
Awareness varies about the availability and effectiveness of ‘miracle’ COVID treatments, experts say. Once in short supply they are now underused.
Moderna’s combination COVID booster appears more protective against variants, company study finds
Concerned that the original vaccine may lose protectiveness as the SARS-CoV-2 virus evolves, companies have been testing different vaccine versions.